Radiotherpay
Showing 1 - 6 of 6
Esophageal Cancer, Chemo Effect, Chemoradiation Trial in Beijing (drug, radiation, procedure)
Recruiting
- Esophageal Cancer
- +6 more
- Platinum based chemotherapy
- +6 more
-
Beijing, ChinaDepartment of Radiation Oncology, National Cancer Center/Nationa
Mar 26, 2021
Breast Carcinoma Trial in Ghent (radiation in prone position, radiation in supine position)
Completed
- Breast Carcinoma
- radiation in prone position
- radiation in supine position
-
Ghent, BelgiumUniversity Hospital Ghent
Dec 15, 2022
Breast Tumors Trial in Beijing (Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy
Recruiting
- Breast Neoplasms
- Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy (26 Gy/5.2Gy/5)
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Nov 1, 2022
Radiotherapy, Toripalimab, Sorafenib Trial in Beijing (Radiotherapy plus Toripalimab, Sorafenib)
Recruiting
- Radiotherapy
- +3 more
- Radiotherapy plus Toripalimab
- Sorafenib
-
Beijing, Beijing, ChinaBo Chen
Mar 6, 2021
Hypopharyngeal Cancer Trial in Beijing (Induction CT+ CRT group, Concurrent CRT group)
Recruiting
- Hypopharyngeal Cancer
- Induction CT+ CRT group
- Concurrent CRT group
-
Beijing, ChinaCancer hospital, Chinese Academy of Medical Sciences
Jan 28, 2021
Non Small Cell Lung Cancer Trial in Wuhan (PD-1/PD-L1 inhibitor)
Suspended
- Non Small Cell Lung Cancer
- PD-1/PD-L1 inhibitor
-
Wuhan, Hubei, ChinaTongji Hospital Affiliated to Tongji Medical College of Huazhong
Apr 6, 2021